Your search for non small cell lung cancer returned 460 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Home remove

Your search for non small cell lung cancer returned 460 results

Sort Results:

Relevant Recent
News

Tecentriq Approved for Non-Small Cell Lung Cancer

Genentech announced that the Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) who have disease progression during or following platinum-containing chemotherapy, and have progressed on an appropriate FDA-approved targeted therapy if their tumor has EGFR or ALK gene abnormalities.